Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
41.52
-0.41 (-0.98%)
At close: Oct 23, 2026, 4:00 PM EDT
42.00
+0.48 (1.16%)
After-hours: Oct 23, 2026, 7:30 PM EDT
Enliven Therapeutics Employees
Enliven Therapeutics had 67 employees as of June 30, 2026. The number of employees increased by 4 or 6.35% compared to the same quarter last year. That makes Enliven Therapeutics the 33,729th largest employer in the world and 4,444th in the United States.
Employees
67
Change (1Y)
4
Growth (1Y)
6.35%
Revenue / Employee
n/a
Profits / Employee
-$1,581,000
Market Cap
3.04B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 67 | 4 | 6.35% |
| Mar 31, 2026 | 61 | -4 | -6.15% |
| Dec 31, 2025 | 60 | -2 | -3.23% |
| Sep 30, 2025 | 65 | 8 | 14.04% |
| Jun 30, 2025 | 63 | 11 | 21.15% |
| Mar 31, 2025 | 65 | 15 | 30.00% |
| Dec 31, 2024 | 62 | 16 | 34.78% |
| Sep 30, 2024 | 57 | 13 | 29.55% |
| Jun 30, 2024 | 52 | 15 | 40.54% |
| Mar 31, 2024 | 50 | 21 | 72.41% |
| Dec 31, 2023 | 46 | 17 | 58.62% |
| Sep 30, 2023 | 44 | 20 | 83.33% |
| Jun 30, 2023 | 37 | 13 | 54.17% |
| Mar 31, 2023 | 29 | - | - |
| Sep 30, 2022 | 24 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Telix Pharmaceuticals | 1,184 |
| Acadia Pharmaceuticals | 798 |
| Denali Therapeutics | 507 |
| Tarsus Pharmaceuticals | 370 |
| Nurix Therapeutics | 317 |
| Dyne Therapeutics | 289 |
| Disc Medicine | 165 |
| Celcuity | 155 |
ELVN News
- 5 days ago - Enliven price target raised to $73 from $65 at H.C. Wainwright - TheFly
- 10 days ago - Enliven Therapeutics Appoints Kristine Ball to Board of Directors Ahead of Planned Phase 3 Trial Initiation this Year - PRNewsWire
- 18 days ago - Enliven reaches alignment with FDA on final design of ENABLE-2 pivotal trial - TheFly
- 18 days ago - Enliven Therapeutics Announces FDA Alignment on ENABLE-2 Phase 3 Trial Design for Relcobatinib (ELVN-001) in Previously Treated Chronic Myeloid Leukemia - PRNewsWire
- 22 days ago - Enliven initiated with an Overweight at Morgan Stanley - TheFly
- 23 days ago - Enliven initiated with an Overweight at JPMorgan - TheFly
- 5 weeks ago - Enliven Therapeutics Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 7 weeks ago - Enliven Therapeutics to Present at Upcoming Investor Conferences - PRNewsWire